ロード中...
In vitro and in vivo activities of DW-3-15, a commercial praziquantel derivative, against Schistosoma japonicum
BACKGROUND: Schistosomiasis is a debilitating neglected tropical disease that affects approximately 190 million people around the world. Praziquantel (PZQ) is the only drug available for use against all Schistosoma species. Although PZQ has a high efficacy, recognized concerns have prompted the deve...
保存先:
| 出版年: | Parasit Vectors |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6500042/ https://ncbi.nlm.nih.gov/pubmed/31053083 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13071-019-3442-7 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|